Case Study: a mid-sized biopharmaceutical company achieves inspection readiness in 27 days with WCG Clinical

Mid-sized Biopharmaceutical Company reaches inspection readiness in 27 days with WCG Clinical

A mid-sized biopharmaceutical company faced a critical challenge when it needed to achieve inspection readiness for an upcoming regulatory submission in just 27 days. The client had complex mock inspection findings and required expert assistance to perform root cause analysis and develop corrective and preventative action (CAPA) plans to address systematic issues in its clinical operations. It engaged WCG Avoca, a service of WCG Clinical, for its quality expertise and access to industry best practices.

WCG Avoca implemented a customized solution that included an in-depth review of findings, root cause analysis, and the development of cohesive CAPA plans. This process improvement support enabled the client to meet its aggressive deadline for inspection readiness. The results were highly successful, with the client awarding a perfect "10 out of 10" satisfaction score and noting the exceptional communication and professionalism of the WCG Avoca team.